RSV Treatment in the Emergency Department
Primary Treatment Approach
- The American Academy of Pediatrics recommends supportive care, focusing on hydration assessment and oxygen supplementation when oxygen saturation falls persistently below 90% 1
Core Supportive Measures
- Assess and maintain adequate hydration and fluid intake for all RSV patients 1
- Provide supplemental oxygen if oxygen saturation falls persistently below 90% in previously healthy infants 1
- Use acetaminophen or ibuprofen for fever or pain management 1
What NOT to Use in the ED
- The American Academy of Pediatrics recommends against routine bronchodilator therapy without documented clinical improvement 1
- Do not use corticosteroids routinely in bronchiolitis management 1
- Do not use ribavirin routinely, except in severely immunocompromised patients, hematopoietic stem cell transplant patients, or mechanically ventilated infants with documented severe RSV infection 1
- Do not use antibacterial medications unless specific indications of bacterial co-infection exist 1
- Do not use palivizumab for treatment, as it has no therapeutic benefit for established RSV infection and is only approved for prevention in high-risk infants 1
Diagnostic Approach
- Perform rapid diagnostic testing to document RSV infection, especially during RSV season, for pediatric patients and immunocompromised adults with respiratory illness 2, 3
Infection Control in the ED
- Hand decontamination before and after direct contact with patients is the single most important measure to prevent transmission 5, 1
- Use alcohol-based rubs as the preferred method for hand decontamination 5, 1
- Wear gloves while handling patients with confirmed or suspected RSV infection and when handling potentially contaminated fomites 2, 3
Special Populations Requiring Different Management
- Consider admission for premature infants, those with cardiopulmonary disease, and immunocompromised patients 1
- Consider ICU transfer for failure to maintain SaO2 >92% in FiO2 >60%, shock, or severe respiratory distress with rising PaCO2 1
Critical Pitfalls to Avoid
- Avoid overuse of antibiotics without evidence of bacterial co-infection, as it contributes to antimicrobial resistance 1
- Avoid continuing bronchodilator therapy without documented clinical improvement 1
- Avoid inadequate infection control measures, leading to nosocomial transmission, and restrict healthcare workers with active upper respiratory symptoms from caring for high-risk infants 1, 2, 3